We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
AllianceBernstein
AB
$3.47B
| $206K | ﹤0.01% |
6,800
| – | – |
|
1802
Deutsche Bank
DB
$66.3B
| $206K | ﹤0.01% |
26,482
-742
| -3% | -$5.57K |
|
1803
Horizon Bancorp
HBNC
$1.03B
| $206K | ﹤0.01% |
10,815
| – | – |
|
1804
Ligand Pharmaceuticals
LGND
$6.02B
| $206K | ﹤0.01% |
3,158
-470
| -13% | -$31.4K |
|
|
GMZ
1805
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
| $206K | ﹤0.01% |
4,857
+3,857
| +386% | +$164K |
|
1806
Parsons
PSN
$6.28B
| $205K | ﹤0.01% |
4,962
+2,207
| +80% | +$82.4K |
|
1807
Tenaris
TS
$29.1B
| $205K | ﹤0.01% |
9,088
-4,125
| -31% | -$88.7K |
|
|
FBC
1808
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $205K | ﹤0.01% |
5,352
+2,502
| +88% | +$93.5K |
|
1809
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17B
| $204K | ﹤0.01% |
5,406
-671
| -11% | -$24.2K |
|
|
PHK
1810
PIMCO High Income Fund
PHK
$861M
| $203K | ﹤0.01% |
27,031
-2,650
| -9% | -$20.3K |
|
1811
US Foods
USFD
$21.4B
| $203K | ﹤0.01% |
4,860
+1,201
| +33% | +$48.2K |
|
|
ATSG
1812
DELISTED
Air Transport Services Group
ATSG
| $203K | ﹤0.01% |
8,669
+4,458
| +106% | +$99.9K |
|
1813
Popular Inc
BPOP
$11B
| $202K | ﹤0.01% |
3,429
| – | – |
|
1814
FirstService
FSV
$6.32B
| $202K | ﹤0.01% |
2,167
| – | – |
|
1815
Cedar Fair
FUN
$1.78B
| $202K | ﹤0.01% |
3,640
-20,582
| -85% | -$1.16M |
|
1816
Hercules Capital
HTGC
$2.94B
| $202K | ﹤0.01% |
14,386
+802
| +6% | +$11.2K |
|
1817
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
| $202K | ﹤0.01% |
5,568
+492
| +10% | +$17.1K |
|
1818
Sociedad Química y Minera de Chile
SQM
$19.6B
| $201K | ﹤0.01% |
7,539
+1,131
| +18% | +$29.8K |
|
1819
Chemours
CC
$2.59B
| $200K | ﹤0.01% |
11,036
+237
| +2% | +$3.94K |
|
1820
WisdomTree US MidCap Fund
EZM
$937M
| $200K | ﹤0.01% |
4,741
| – | – |
|
1821
Federal Signal
FSS
$7.25B
| $200K | ﹤0.01% |
6,194
| – | – |
|
1822
Vale
VALE
$62.9B
| $200K | ﹤0.01% |
15,182
-1,047
| -6% | -$12.6K |
|
1823
Avanos Medical
AVNS
$1.17B
| $199K | ﹤0.01% |
5,932
+54
| +0.9% | +$1.96K |
|
|
CBD
1824
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $199K | ﹤0.01% |
9,127
-338
| -4% | -$6.78K |
|
1825
Brookfield Infrastructure Partners
BIP
$18.8B
| $198K | ﹤0.01% |
6,656
-34
| -0.5% | -$1.02K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.